Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Exploring how anti-HER2 immunoliposomes deliver EPR imaging probes to detect HER2-positive breast cancer micrometastases with unprecedented precision.